Philips RT250 Collimator PK8050
Perkins Mfg.
FDA Clearance Information
The Philips RT250 Collimator PK8050 was cleared through the FDA 510(k) pathway on June 1, 1989. It is manufactured by Perkins Mfg. and classified as a Class 2 device under product code KQA.
What It Is
FDA-Cleared Indications
- Use with compatible 250 kVp x-ray therapy equipment to collimate and shape therapeutic x-ray beams.
- Use during radiation therapy when a defined treatment field is required.
Clinical Applications
- Shaping therapeutic x-ray beams for external-beam radiation treatment.
- Limiting the radiation field to the prescribed treatment area.
- Supporting treatment planning and delivery with compatible 250 kVp x-ray machines.
- Use by radiation oncology teams and medical physicists in appropriately equipped treatment facilities.
Practical Considerations
- Compatibility is specified with 250 kVp x-ray therapy equipment; confirm mechanical, electrical, and radiation-system compatibility before use.
- Proper installation, alignment, calibration, and radiation-output verification are required before clinical treatment.
- The available field sizes and shaping capability should be confirmed from the device documentation and the connected therapy system; they are not established by the FDA record provided here.
- This is an external radiation-treatment accessory, not an implantable or intravascular device.
- MRI safety is not established in the FDA record provided. Do not bring the collimator into an MRI environment unless its MR safety status has been specifically verified.
Related Literature
Linked Studies (20)
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What is the Philips RT250 Collimator PK8050 used for?
It is used in radiation therapy to shape and direct x-ray beams for precise targeting of treatment areas.
What specialties typically use this device?
Radiation oncologists and medical physicists commonly use this device in therapeutic settings.
What are the FDA-cleared indications?
The device is indicated for use in procedures involving embolization-liquid-agents, requiring precise radiation targeting.